The Office for Cancer Comparative Effectiveness Research is an inter-programmatic office at Dartmouth Cancer Center that was established in 2009 to promote and facilitate the conduct of comparative effectiveness research (CER) in cancer.
The Institute of Medicine defines CER as "…the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care."
CER is conducted at the interface between clinical research and health services research and makes use of data from diverse sources.
The Office for Cancer Comparative Effectiveness Research interacts with Dartmouth Cancer Center Research Programs and Shared Resources, and other Dartmouth Research Centers. It promotes CER by providing access to methodological expertise and by facilitating access to diverse data resources including administrative claims data and registry data. The Office also supports a CER Pilot Grant program within the Cancer Center and the multi-institutional Center for Comparative Effectiveness Research in Cancer Imaging.
The Dartmouth Cancer Center Office for Cancer Comparative Effectiveness Research (CER) is directed by Anna Tosteson, ScD, Professor of Medicine, of Community and Family Medicine and of The Dartmouth Institute, and is supported by faculty with methodological expertise in the following areas:
- Clinical Decision Analysis
- Clinical Trials
- Cost-Effectiveness Analysis
- Diagnostic Test/Technology Assessment
- Disease Registries
- Image-Based Research
- Health Services Research
- Health-Related Quality of Life Measurement Methodology
- Medicare Claims Data
- Statistics and Statistical Computing
- Systematic Review/Meta-Analysis
For more information, please contact:
Loretta Pearson, MPhil, CCRC
The Dartmouth Institute for Health Policy & Clinical Practice
Geisel School of Medicine at Dartmouth
HB 7505, Rubin 5 Room 567
One Medical Center Drive
Lebanon NH 03756